Dr. Kostopoulos-Kanitakis is from the School of Medicine, European University of Cyprus, Nicosia. Dr. Kanitakis is from the Department of Dermatology, Edouard Herriot Hospital, Lyon, France.
Cutis. 2023 Apr;111(4):E19-E27. doi: 10.12788/cutis.0757.
COVID-19 is an infectious disease caused by SARS-CoV-2, which emerged in China in 2019 and rapidly spread worldwide to become a pandemic in March 2020. Although the most severe manifestations concern the lower respiratory tract, COVID-19 is a multiorgan disease that also affects the skin. Several types of skin lesions have been reported to be associated with SARS-CoV-2 infection, though their causal relationship with the virus has not yet been well documented. In addition to the cutaneous manifestations that develop in patients with COVID-19-thought to be caused by the virus-other findings associated with the pandemic in a broader sense include dermatoses triggered or aggravated by the infection, the adverse cutaneous effects due to the drugs and protective devices used to prevent or fight the infection, and the adverse cutaneous effects of COVID-19 vaccines. We provide an overview of these dermatoses associated with the COVID-19 pandemic.
新型冠状病毒肺炎（COVID-19）是由 SARS-CoV-2 引起的传染病，该病毒于 2019 年在中国出现，并迅速在全球范围内传播，于 2020 年 3 月成为大流行。尽管最严重的表现涉及下呼吸道，但 COVID-19 是一种多器官疾病，也会影响皮肤。据报道，有几种类型的皮肤损伤与 SARS-CoV-2 感染有关，但它们与病毒之间的因果关系尚未得到充分证实。除了在 COVID-19 患者中出现的、被认为是由病毒引起的皮肤表现外，更广泛意义上的大流行还包括由感染引发或加重的其他皮肤病、因预防或对抗感染而使用的药物和防护设备引起的不良皮肤效应，以及 COVID-19 疫苗的不良皮肤效应。我们对与 COVID-19 大流行相关的这些皮肤病进行了概述。
